Fig. 12
Quantitative analysis of VG staining of each group at 4, 8, and 12 weeks after treatment (ns, p ≥ 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001)
Fig. 12 | BMC Musculoskeletal Disorders
Quantitative analysis of VG staining of each group at 4, 8, and 12 weeks after treatment (ns, p ≥ 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001)